Valuation: Medpace Holdings, Inc.

Market Cap 1.86TCr 1.68TCr 1.55TCr 1.4TCr 2.65TCr 1,74300Cr 2.71TCr 19TCr 7.39TCr 93TCr 6.98TCr 6.83TCr 2,97100Cr P/E 2026 *
36.5x
P/E 2027 * 33.9x
Enterprise Value 1.78TCr 1.6TCr 1.48TCr 1.34TCr 2.53TCr 1,66700Cr 2.59TCr 18TCr 7.07TCr 89TCr 6.67TCr 6.53TCr 2,84200Cr EV / Sales 2026 *
6.24x
EV / Sales 2027 * 5.73x
Free-Float
81.14%
Yield 2026 *
-
Yield 2027 * -
1 day+0.31%
1 week+1.57%
Current month+2.32%
1 month+7.59%
3 months+10.18%
6 months+59.87%
Current year+18.78%
1 week 632.11
Extreme 632.11
679.18
1 month 605.76
Extreme 605.76
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+1.57%+10.67%+141.82% 1.86TCr
-1.06%+9.92%+59.12%+68.61% 6.83TCr
+1.30%+7.41%+14.79%+90.26% 6.03TCr
+0.39%+0.30%+20.04%+97.74% 5.59TCr
-0.89%+11.24%+22.29%+111.34% 4.84TCr
+0.98%+5.62%+27.50%+43.86% 4.53TCr
-5.48%-8.86%+184.02%+826.21% 4.18TCr
+1.97%+9.00%+25.20%+50.98% 3.45TCr
-0.56%-0.48%+85.57%+57.71% 3.38TCr
-1.49%+13.52%+43.09%+0.06% 2.6TCr
Average -0.47%+3.88%+49.23%+148.86% 4TCr
Weighted average by Cap. -0.45%+3.87%+48.84%+147.44%

Financials

2026 *2027 *
Net sales 284.96Cr 256.83Cr 237.28Cr 214.5Cr 405.82Cr 27TCr 415.84Cr 2.84TCr 1.13TCr 14TCr 1.07TCr 1.05TCr 46TCr 302.13Cr 272.31Cr 251.58Cr 227.43Cr 430.28Cr 28TCr 440.9Cr 3.02TCr 1.2TCr 15TCr 1.13TCr 1.11TCr 48TCr
Net income 52Cr 47Cr 43Cr 39Cr 74Cr 4.88TCr 76Cr 519.47Cr 207.05Cr 2.61TCr 195.36Cr 191.21Cr 8.32TCr 55Cr 50Cr 46Cr 42Cr 79Cr 5.19TCr 81Cr 552.62Cr 220.26Cr 2.78TCr 207.83Cr 203.41Cr 8.85TCr
Net Debt -81Cr -73Cr -68Cr -61Cr -115.6Cr -7.61TCr -118.45Cr -810.01Cr -322.85Cr -4.08TCr -304.62Cr -298.15Cr -13TCr -127.23Cr -114.67Cr -105.94Cr -96Cr -181.19Cr -12TCr -185.66Cr -1.27TCr -506.04Cr -6.39TCr -477.48Cr -467.33Cr -20TCr
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
11/26/11 $667.11 +0.39% 53,969
10/26/10 $664.54 -1.25% 1,65,203
09/26/09 $672.93 +3.03% 2,19,169
06/26/06 $653.11 +2.86% 2,31,625
05/26/05 $634.98 -3.32% 3,15,868
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
664.54USD
Average target price
651.31USD
Spread / Average Target
-1.99%
  1. Stock Market
  2. Stocks
  3. MEDP Stock